PharmEasy has acquired Bengaluru-based healthcare supply chain startup Aknamed for $150-200 million, ET NOW reported citing sources. This would mark the online pharmacy startup's second acquisition this year. Earlier in June, it bought a 66.1% stake in listed diagnostics firm Thyrocare for ₹4,546 crore (about $611 million), becoming India's first unicorn startup to acquire a listed company.